La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Molecular Structure »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Molecular Sequence Data < Molecular Structure < Molecular Targeted Therapy  Facettes :

List of bibliographic references indexed by Molecular Structure

Number of relevant bibliographic references: 8.
Ident.Authors (with country if any)Title
000188 (2016) Michel Boutin ; Ying Sun [États-Unis] ; John J. Shacka [États-Unis] ; Christiane Auray-BlaisTandem Mass Spectrometry Multiplex Analysis of Glucosylceramide and Galactosylceramide Isoforms in Brain Tissues at Different Stages of Parkinson Disease.
000877 (2014) Philippe Huot [Canada] ; Tom H. Johnston [Canada] ; Katie D. Lewis [Australie] ; James B. Koprich [Canada] ; M Gabriela Reyes [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Jonathan M. Brotchie [Canada]UWA-121, a mixed dopamine and serotonin re-uptake inhibitor, enhances L-DOPA anti-parkinsonian action without worsening dyskinesia or psychosis-like behaviours in the MPTP-lesioned common marmoset.
000937 (2014) Donald A. Mcafee [Canada] ; Jonathan Hadgraft [Royaume-Uni] ; Majella E. Lane [Royaume-Uni]Rotigotine: the first new chemical entity for transdermal drug delivery.
000A37 (2014) Plamena R. Angelova [Canada] ; Bikram Keshari Agrawalla ; Pia A. Elustondo ; Jacob Gordon ; Toshikazu Shiba ; Andrey Y. Abramov ; Young-Tae Chang ; Evgeny V. PavlovIn situ investigation of mammalian inorganic polyphosphate localization using novel selective fluorescent probes JC-D7 and JC-D8.
001278 (2012) Jihane Ismaili [Canada] ; Martin Boisvert ; Fanny Longpré ; Julie Carange ; Céline Le Gall ; Maria-Grazia Martinoli ; Benoit DaoustBrassinosteroids and analogs as neuroprotectors: synthesis and structure-activity relationships.
001689 (2011) Tarek Mohamed [Canada] ; Jacky C K. Yeung ; Praveen P N. RaoDevelopment of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation.
002B89 (2004) Tom H. Johnston [Canada] ; Jonathan M. BrotchieDrugs in development for Parkinson's disease.
004863 (1990) D. Brewer ; V O Parkinson ; A. TaylorA note on the antibacterial properties of 3-(3'-isocyanocyclopent-2'-enylidene)propionic acid in the ovine rumen.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Molecular Structure" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Molecular Structure" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Molecular Structure
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022